21474 Federal Register / Vol. 61, No. 92 / Friday, May 10, 1996 / Notices

Dated: April 23, 1996.

Eugene C. Coleman,

Acting Director, Office of Premarket

Approval, Center for Food Safety and Applied

Nutrition.

[FR Doc. 96–11789 Filed 5–9–96; 8:45 am]

BILLING CODE 4160–01–F

Health Care Financing Administration

[R–66]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, has submitted to the

Office of Management and Budget

(OMB) the following proposal for the

collection of information. Interested

persons are invited to send comments

regarding the burden estimate or any

other aspect of this collection of

information, including any of the

following subjects: (1) The necessity and

utility of the proposed information

collection for the proper performance of

the agency’s functions; (2) the accuracy

of the estimated burden; (3) ways to

enhance the quality, utility, and clarity

of the information to be collected; and

(4) the use of automated collection

techniques or other forms of information

technology to minimize the information

collection burden.

Type of Information Collection

Request: Reinstatement, without change,

of previously approved collection for

which approval has expired; Title of

Information Collection: Hospice Core

Service: Nursing Information Collection;

Form No.: HCFA–R–66; Use: Hospice

applying for a waiver to the nursing core

services requirements must submit

documentation to HCFA supporting

their request. Frequency: Other, one

time only; Affected Public: Business or

other for-profits and Not-for-profit

institutes; Number of Respondents: 1;

Total Annual Responses: 1; Total

Annual Hours Requested: 1.

To request copies of the proposed

paperwork collections referenced above,

E-mail your request, including your

address, to Paperwork@hcfa.gov, or call

the Reports Clearance Office on (410)

786–1326. Written comments and

recommendations for the proposed

information collections should be sent

within 30 days of this notice directly to

the OMB Desk Officer designated at the

following address: OMB Human

Resources and Housing Branch,

Attention: Allison Eydt, New Executive

Office Building, Room 10235,

Washington, D.C. 20503.

Dated: May 2, 1996.

Kathleen B. Larson,

Director, Management Planning and Analysis

Staff, Office of Financial and Human

Resources, Health Care Financing

Administration.

[FR Doc. 96–11651 Filed 5–9–96; 8:45 am]

BILLING CODE 4120–03–P

National Institutes of Health

Division of Research Grants; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review Small

Business Innovation Research.

Name of SEP: Biological and Physiological

Sciences.

Date: May 14–15, 1996.

Time: 9:00 a.m.

Place: Savory Suites Hotel, Washington,

DC.

Contact Person: Dr. Anita Sostek, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 5202, Bethesda, Maryland 20892, (301)

435–1260.

Name of SEP: Biological and Physiological

Sciences.

Date: May 15, 1996.

Time: 11:00 a.m.

Place: Savoy Suites Hotel, Washington, DC.

Contact Person: Dr. Anita Sostek, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 5202, Bethesda, Maryland 20892, (301)

435–1260.

This notice is being published less than 15

days prior to the above meetings due to the

urgent need to meet timing limitations

imposed by the grant review and funding

cycle.

Name of SEP: Chemistry and Related

Sciences.

Date: June 16–18, 1996.

Time: 8:00 a.m.

Place: Bethesda Hyatt, Bethesda, MD.

Contact Person: Dr. Marjam Behar,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5218, Bethesda,

Maryland 20892, (301) 435–1180.

Name of SEP: Clinical Sciences.

Date: July 17, 1996.

Time: 8:00 a.m.

Place: Double Tree Hotel, Rockville, MD.

Contact Person: Dr. Gertrude McFarland,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4110, Bethesda,

Maryland 20892, (301) 435–1284.

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Behavioral and

Neurosciences.

Date: May 17, 1996.

Time: 2:00 p.m.

Place: NIH, Rockledge 2, Room 5172,

Telephone Conference.

Contact Person: Dr. Leonard Jakubczak,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5172, Bethesda,

Maryland 20892, (301) 435–1247.

This notice is being published less than 15

days prior to the above meeting due to the

urgent need to meet timing limitations

imposed by the grant review and funding

cycle.

Name of SEP: Chemistry and Related

Sciences.

Date: June 17, 1996.

Time: 8:00 a.m.

Place: Bethesda Hyatt, Bethesda, MD.

Contact Person: Dr. Marjam Behar,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5218, Bethesda,

Maryland 20892, (301) 435–1180.

Name of SEP: Biological and Physiological

Sciences.

Date: June 19–21, 1996.

Time: 8:30 a.m.

Place: Holiday Inn, Chevy Chase, MD.

Contact Person: Dr. Lynwood Jones,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4192, Bethesda,

Maryland 20892, (301) 435–1153.

Name of SEP: Behavioral and

Neurosciences.

Date: June 26–28, 1996.

Time: 8:00 a.m.

Place: The Jefferson Hotel, Washington,

DC.

Contact Person: Dr. David Simpson,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5192, Bethesda,

Maryland 20892, (301) 435–1278.

Name of SEP: Micobiological and

Immunological Sciences.

Date: July 11–12, 1996.

Time: 8:00 a.m.

Place: Holiday Inn, Bethesda, MD.

Contact Person: Dr. Jean Hickman,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4178, Bethesda,

Maryland 20892, (301) 435–1146.

The meetings will be closed in accordance

with the provisions set fort in secs. 552b(c)(4)

and 552b(c)(6), Title 5, U.S.C. Applications

and/or proposals and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS).

Dated: May 3, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–11642 Filed 5–9–96; 8:45 am]

BILLING CODE 4140–01–M